We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$226M
2
MSFT icon
Microsoft
MSFT
+$205M
3
TSLA icon
Tesla
TSLA
+$83.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$65.6M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$64.9M

Top Sells

Rank Stock Value
1
SQM icon
Sociedad Química y Minera de Chile
SQM
+$60.4M
2
META icon
Meta Platforms (Facebook)
META
+$39.1M
3
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$36.9M
4
BKNG icon
Booking.com
BKNG
+$28M
5
SYK icon
Stryker
SYK
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HST icon
251
Host Hotels & Resorts
HST
$17.5B
$10.9M 0.08%
684,918
+622,979
+1,006% +$10.9M
ISEE
252
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$10.8M 0.08%
602,832
-863,739
-59% -$11.3M
CTXS
253
DELISTED
Citrix Systems Inc
CTXS
$10.8M 0.08%
103,588
+37,593
+57% +$3.85M
NRIX icon
254
Nurix Therapeutics
NRIX
$2.45B
$10.8M 0.08%
825,575
-13,800
-2% -$218K
MDB icon
255
MongoDB
MDB
$25.8B
$10.7M 0.08%
54,080
+50,163
+1,281% +$14.6M
WAB icon
256
Wabtec
WAB
$49.3B
$10.6M 0.08%
130,774
+14,108
+12% +$1.25M
GTM
257
ZoomInfo Technologies
GTM
$1.03B
$10.6M 0.07%
+254,166
New +$10.8M
REPL icon
258
Replimune Group
REPL
$454M
$10.5M 0.07%
609,572
+117,068
+24% +$2.23M
ESGR
259
DELISTED
Enstar Group
ESGR
$10.4M 0.07%
+61,354
New +$12M
ATVI
260
DELISTED
Activision Blizzard
ATVI
$10.3M 0.07%
138,966
+92,088
+196% +$7.21M
FATE icon
261
Fate Therapeutics
FATE
$275M
$10.3M 0.07%
460,436
+236,403
+106% +$6.83M
BKNG icon
262
Booking.com
BKNG
$156B
$10.3M 0.07%
156,675
-372,575
-70% -$28M
AFL icon
263
Aflac
AFL
$65.5B
$10.2M 0.07%
182,185
+36,548
+25% +$2.15M
WFC icon
264
Wells Fargo
WFC
$254B
$10.2M 0.07%
253,771
-11,674
-4% -$502K
GH icon
265
Guardant Health
GH
$19.1B
$10.2M 0.07%
189,050
+39,469
+26% +$2.03M
PTCT icon
266
PTC Therapeutics
PTCT
$6.18B
$10.2M 0.07%
202,652
– –
DXCM icon
267
DexCom
DXCM
$29B
$10.2M 0.07%
126,069
-1,630
-1% -$138K
CRL icon
268
Charles River Laboratories
CRL
$11.3B
$10.1M 0.07%
51,454
-2,353
-4% -$508K
GNW icon
269
Genworth Financial
GNW
$3.86B
$10.1M 0.07%
+2,882,014
New +$11.6M
RHI icon
270
Robert Half
RHI
$4.11B
$10M 0.07%
130,969
+11,278
+9% +$882K
UDR icon
271
UDR
UDR
$12.9B
$10M 0.07%
239,788
+184,681
+335% +$8.47M
STRO icon
272
Sutro Biopharma
STRO
$386M
$9.98M 0.07%
179,884
+173,623
+2,773% +$10.3M
NTR icon
273
Nutrien
NTR
$33.9B
$9.93M 0.07%
14,840
+918
+7% +$79K
CRNC icon
274
Cerence
CRNC
$359M
$9.88M 0.07%
627,117
+3,844
+0.6% +$86.3K
UMPQ
275
DELISTED
Umpqua Holdings Corp
UMPQ
$9.84M 0.07%
575,571
-319,342
-36% -$5.67M
9 10
11
12 13

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.